SABER UCV >
1) Investigación >
Artículos Publicados >

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10872/19841

Título : Evaluation of the transcriptional immune biomarkers in peripheral blood from Warao indigenous associate with the infection by Mycobacterium tuberculosis
Autor : Araujo, Zaida
Palacios, Andrea
Enciso-Moreno, Leonor
Lopez-Ramos, Juan Ernesto
Wide, Albina
De Waard, Jacobus
Rivas-Santiago, Bruno
Serrano, Carmen
Bastian-Hernandez, Yadira
Enciso-Moreno, Jose
Palabras clave : Tuberculosis.
Warao indigenous
Immune biomarker
Real-time quantitative PCR (qPCR).
Fecha de publicación : 2019
Editorial : Revista da Sociedade Brasileira de Medicina Tropical
Citación : Araujo. Z Et All Evaluation of the transcriptional immune biomarkers in peripheral blood from Warao indigenous associate with the infection by Mycobacterium tuberculosis Vol. 52 2019
Citación : Vol.;52
Resumen : Introduction: Biomarkers are critical tools for finding new approaches for controlling the spread of tuberculosis (TB), including for predicting the development of TB therapeutics, vaccines, and diagnostic tools. Methods: We analyzed transcriptional immune biomarkers ex vivo and in M. tuberculosis antigens (ESAT-6, CFP10, and TB7.7) in stimulated peripheral blood of Warao indigenous individuals. These biomarkers may be able to differentiate TB states, such as active tuberculosis (ATB) cases and latent tuberculosis infection (LTBI) from non-infected controls (NIC). A real-time reverse transcription polymerase chain reaction (RT-qPCR) assay was performed on 100 blood samples under non-stimulation or direct ex vivo conditions (NS=50) and stimulation conditions (S=50). Results: The findings are shown as the median and interquartile range (IQR) of relative gene expression levels of IFN-γ, CD14, MMP9, CCR5, CCL11, CXCL9/MIG, and uPAR/PLAUR immune biomarkers. MMP9 levels were significantly higher in the LTBI-NS and LTBI-S groups compared with the NIC-NS and NIC-S groups. However, CCR5 levels were significantly lower in the LTBI-S group compared with both NIC-NS and NIC-S groups. CCL11 levels were significantly lower in the LTBI-S group compared with the NIC- NS group. Conclusions: Preliminary findings showed that MMP9 immune biomarkers separated LTBI indigenous individuals from NIC indigenous individuals, while CCR5, CCL11, CD14, and IFN-γ did not differentiate TB states from NIC. MMP9 may be useful as a potential biomarker for LTBI and new infected case detection among Warao indigenous individuals at high risk of developing the disease. It may also be used to halt the epidemic, which will require further validation in larger studies.
URI : http://hdl.handle.net/10872/19841
ISSN : 1678-9849
Aparece en las colecciones: Artículos Publicados

Ficheros en este ítem:

Fichero Descripción Tamaño Formato
Araujo.et.al.2019.pdf1.38 MBAdobe PDFVisualizar/Abrir

Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2008 MIT and Hewlett-Packard - Comentarios